(Unlearned) lessons from John Graunt and Kenneth Rothman: A "CLASSic" example

Guardado en:

書目詳細資料
發表在:	Clinical Therapeutics vol. 25, no. 11 (Nov 2003), p. 2891
主要作者:	Arellano, Felix M.
企業作者:	Class
其他作者:	Castellsague, Jordi
出版:	Elsevier Limited
主題:	Anti-Inflammatory Agents, Non-Steroidal > adverse effects Data Interpretation, Statistical Endpoint Determination Epidemiologic Methods Epidemiologic Research Design Humans Peptic Ulcer > chemically induced Randomized Controlled Trials as Topic
在線閱讀:	Citation/Abstract Full Text Full Text - PDF
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

實物特徵
Resumen:	This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Lonngterm Arthritis Safety Study. This commentary reviews the work of John Graunt and Kenneth J. Rothman on statistical significance and the need for prespecification of study end points. The authors argue that it is dangerous to substitute oversimplifications based exclusively on whether a result has reached statistical significance for a rational process of causal inference. An example is given based on the Celecoxib Long-term Arthritis Safety Study.
ISSN:	0149-2918 1879-114X
DOI:	10.1016/S0149-2918(03)80341-7
Fuente:	Healthcare Administration Database